Cost-effectiveness of Statin Therapy for ASCVD--Reply

JAMA. 2015 Nov 24;314(20):2191-2. doi: 10.1001/jama.2015.12928.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atherosclerosis / drug therapy*
  • Cardiovascular Diseases / prevention & control*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Quality-Adjusted Life Years*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors